Publication | Open Access
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
26
Citations
31
References
2022
Year
https://clinicaltrials.gov/, identifier NCT03662815.
| Year | Citations | |
|---|---|---|
Page 1
Page 1